|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01526 RICI HEALTH
Nominal 
1.200 +0.030 (+2.564%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 1,231,205 | -4.137% | 2,992,689 | 2,375,027 | 2,506,522 | 1,925,190 |
| Cost of Sales | (834,918) | 4.325% | (1,743,180) | (1,447,825) | (1,607,397) | (1,344,526) |
| Gross Profit | 396,287 | -18.128% | 1,249,509 | 927,202 | 899,125 | 580,664 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 1,871 | -- | (9,042) | 3,448 | (1,801) | 1,340 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 417 | -5.227% | 958 | 419 | 803 | 775 | |
| Profit / (Loss) before Taxation | 125,148 | -30.449% | 545,632 | 327,190 | 227,477 | (108,823) | |
| Taxation | (38,027) | -29.210% | (143,657) | (84,041) | (101,372) | 16,326 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | 24,038 | -- | -- | |
| Non-controlling Interests | (2,130) | -25.237% | (38,172) | 23,606 | 55,448 | 84,621 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 84,991 | -31.109% | 363,803 | 290,793 | 181,553 | (7,876) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 60,966 | 24.321% | 112,246 | 104,907 | 156,706 | 185,378 |
| Depreciation & Amortisation | 216,506 | 12.403% | 396,838 | 340,803 | 384,511 | 371,540 |
| Directors' Emoluments | -- | -- | 3,654 | 6,105 | 8,489 | 8,769 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 5.000 | -37.500% | 23.000 | 18.000 | 11.000 | -0.500 |
| DPS (cts) | 0.000 | -- | 11.771 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | 51.179% | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.520 | 0.444 | 0.428 | 0.280 |
| NBV per share ($) | 0.762 | -- | 0.709 | 0.600 | 0.426 | 0.318 |
| Remarks: | Real time quote last updated: 27/12/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 84,991 |
| %Change | -31.109% |
| EPS / (LPS) | RMB 0.050 |
| NBV Per Share (¥) | RMB 0.762 |